Rare Product Safety Problems Can Trigger Recalls – Consultant
This article was originally published in The Gray Sheet
Executive Summary
Companies should notify FDA of corrections to product labeling that could affect safety, even if the problem addressed is extremely rare, according to Anson Group Managing Partner Colleen Densmore